Amgen (AMGN) PT Lowered to $304 at BMO Capital

October 29, 2020 7:01 AM EDT Send to a Friend
BMO Capital analyst Do Kim lowered the price target on Amgen (NASDAQ: AMGN) to $304.00 (from $308.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login